Whalegun
Home

Samuel Kintz, President and CEO: Enliven Therapeutics ELVN Sell · Filed 25/08/20

Trade details

Type
Insider sale
Amount
$208,067.86
Shares · price
10,393 sh · $20.02 a share
Held after
929,999 sh
Stock
Enliven Therapeutics ELVN
Person
Samuel KintzPresident and CEO
Trade date
25/08/18
Filed
25/08/20
Days to filing
2 days

Sold 1.1% of holdings

Share of holding sold
1.1%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 25/07/19~25/09/17

Samuel Kintz's recent trades

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $2M

    Filed 02/17

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $1.7M

    Filed 01/09

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $1.3M

    Filed 01/08

  • Samuel Kintz

    Planned sale10b5-1 planEnliven Therapeutics

    $84.6K

    Filed 25/12/17

  • Samuel Kintz

    Sell10b5-1 planEnliven Therapeutics

    $272.8K

    Filed 25/11/19

Samuel Kintz, CEO — sold $208.1K of Enliven Therapeutics ELVN · 1.1% of holdings · 10b5-1 plan | Whalegun